Kg In Control Group Research Articles

Role of Whey Protein in the Treatment Outcome of Maxillofacial Trauma Patients: An Interventional Study.

Maxillofacial fracture severely affects the diet of the patients leading to reduction of body weight. Facial trauma affects the muscles of mastication and the bones of face leading to reduction in bite force. The purpose of our study was to investigate the effect of whey protein supplement in the postoperative period of maxillofacial trauma patients with respect to body weight, bite force and callus formation. Patients were divided into control group and study group having 20 patients each. The control group received usual modified diet for maxillofacial fracture and study group received same diet along with whey protein for 6weeks. There was mean weight loss of 3.15kg in control group whereas there was no weight loss of in the study group. There was statistically significant increase in bite force in the study group compared to the control group with p value < 0.05. Early callus formation was seen in study group compared to control group. Our results showed that patients who were supplemented with whey protein had no loss of body weight, better masticatory efficiency, better healing of the fracture sites and overall early recovery.

A STUDY TO ASSESS THE EFFECTIVENESS OF STRETCHING EXERCISES ON LEVEL OF MUSCLE CRAMPS DURING HEMODIALYSIS AMONG CKD PATIENTS IN SELECTED HOSPITAL AT DEHRADUN (UTTARAKHAND)

A STUDY TO ASSESS THE EFFECTIVENESS OF STRETCHING EXERCISES ON LEVEL OF MUSCLE CRAMPS DURING HEMODIALYSIS AMONG CKD PATIENTS IN SELECTED HOSPITAL AT DEHRADUN (UTTARAKHAND)

The Effect of Lifestyle Intervention to Prevent Excessive Weight Gain During Pregnancy and Promote Postpartum Weight Loss in Overweight and Obese Women

1.1. Objective: To assess the efficacy of a theory-based lifestyle counselling intervention sessions in overweight and obese women for the prevention of excessive pregnancy weight gain and indorse postpartum weight loss. 1.2. Methods: Participants with singleton pregnancy at a 12th week of gestation, 18–40 years and BMI ≥ 25 ≤ 40 kg/m2 were included. The pregnant women were randomized to intervention and control group. Three face-to-face lifestyle counselling sessions was attended during the pregnancy (at 12-16, 16-20 and 30- 34 weeks) and one after delivery at 6-8 weeks’ postpartum stage by the intervention group participants. While, the control group received routine prenatal care. The guidelines of the Institute of Medicine (IOM) were used for the gestational weight gain assessment. 1.3. Results: We included 25 women in intervention and 24 in control group in this study. There was no statistically significant difference between the demographic features of the two groups. The mean pre-pregnancy weight was 27.8 kg in intervention and 29.4 kg in control group. The intervention group gained an average less total weight gain (12.23 kg) as compared to control group (18.64 kg); P -value 0.002. The IOM weight gain guidelines were met by 52% of the intervention group. In the intervention group, 28% of pregnant women gained more weight than the IOM guidelines, but this ratio was higher (95.8%) in the control group. Additionally, by 6-8 week of postpartum, revealed that intervention group women were significantly more likely to be at or below their early pregnancy weights as compared to control group (72% vs. 29.1%, p=0.003). 1.4. Conclusion: In our study, lifestyle counselling intervention had a statistically significant impact on the prevention of weight gain or postpartum weight loss in overweight or obese pregnant women. The observed effects are needed to be confirmed in further large randomized studies.

Maternal anemia in various trimesters of singleton pregnancies and its correlation with birth weight: An observational study

Background: Anemia is a very important preventable nutritional disorder affecting pregnant ladies which may have some adverse effects on the neonatal survival and development. Birth weight was correlated with changes in maternal hemoglobin concentration in various trimesters as it is important for determining child survival and development. Aims and Objectives: The aim of the study was to assess the correlation between maternal hemoglobin levels in various trimesters and neonatal birth weight. Materials and Methods: The study enrolled all pregnant women within age group 15–35 years who gave birth at Agartala Government Medical College and GBP Hospital from June 15, 2017 to August 15, 2017. Pregnant women were included into the study following delivery by simple random sampling into cases (Pregnant women who delivered low birth weight babies &lt;2500 g) and control group (Pregnant women who delivered normal birth weight babies ≥2500 g). Antenatal data were collected from hospital case sheet and labor room register. Data were analyzed using descriptive statistics and presented as Mean + SD. P &lt; 0.05 (P &lt; 0.05) was considered statistically significant. Results: Mean hemoglobin concentration was normal (˃11 g/dl) in all three trimesters among the controls but it is found to be &lt;11 g/dl in second and third trimesters of the case group. The mean birth weight of the babies was 2.151(± 0.2386) kg in case group and 3.047(± 0.3666) kg in control group. Conclusions: It was found that maternal hemoglobin concentration has a positive correlation (r &gt; 0) with neonatal birth weight in all three trimesters in both cases and controls which is statistically significant (P &lt; 0.05).

728-P: Effects of Using Smaller Bowls on Adherence to Rice Intake Recommendations in Japanese Patients with Diabetes

This study focuses on Japanese type 2 diabetes outpatients with a rice intake higher than the recommended limit. We studied the use of smaller-than-conventional rice bowls in daily life and conducted a prospective study to assess its impacts on adherence to rice intake recommendations, weight, HbA1c value, and DDRQOL scores for 3 months. We selected 72 male participants whose current rice intake larger than guidelines, and whose rice bowls at home are larger than the recommended size. Study participants were randomly divided into two groups. The intervention group (IG) consisted of 36 participants who were asked to use a designated rice bowl smaller than that they normally use. A control group (CG) of 36 participants used their usual rice bowls. Both groups received dietary recommendations for rice intake from doctors at the start of the study. A questionnaire was administered at baseline and at the 1-month and 3-month marks. This interim report compared patients’ adherence to rice intake recommendations, HbA1c value, and so on at the baseline and 1-month marks. With respect to the patients’ adherence to rice intake recommendations at 1 month, 19 participants out of 36 (52.8%) in IG responded that they “mostly did,” while only 10 subjects out of 36 (27.8%) in CG responded the same; more subjects in IG adhered to recommendations (p = 0.040). The mean weights of the subjects at the start of study was 74.2 kg in IG and 78.4 kg in CG. Mean HbA1c values were 6.74% in IG and 6.63% in CG. Neither indices showed any significance. The change in body weight over 1 month was -0.43 kg in IG and 0.27 kg in CG. The change in HbA1c values was -0.15% in IG and 0.09 % in CG. IG revealed a significant decrease in both factors (p = 0.004, p = 0.005 respectively). There was no significant difference in DDRQOL scores. The results suggest that smaller rice bowls increase patients’ adherence to the recommended rice intake, leading to a decrease in body weight and HbA1c values. Disclosure S. Sato: None. M. Shimpo: None. T. Tosaki: Research Support; Self; Abbott, Astellas Pharma Inc., AstraZeneca, Daiichi Sankyo, Kowa Company, Ltd., Lilly Diabetes, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd. H. Kamiya: Speaker’s Bureau; Self; Astellas Pharma Inc., AstraZeneca K.K., Boehringer Ingelheim K.K., Daiichi Sankyo, Eli Lilly Japan K.K., Fukuda Denshi, Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, MSD K.K., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sumitomo Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited. M. Kondo: None. M. Kato: None. H. Shimoda: None. J. Nakamura: Research Support; Self; Astellas Pharma Inc., Boehlinger Ingelheim Japan Co., Ltd., Daiichi Sankyo, Eli Lilly Japan K.K., Japan Tobacco Inc., Kaken Pharmaceutical Co., Ltd., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, MSD K.K., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sanofi K.K., Sanwa Kagaku Kenkyusho, Shionogi &amp; Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited. Speaker’s Bureau; Self; Abbott Japan Co., Ltd., ARKRAY, Astellas Pharma Inc., AstraZeneca K.K., Boehlinger Ingelheim Japan Co., Ltd.,, Daiichi Sankyo, Eli Lilly Japan K.K., Fukuda Denshi, Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Mitsubishi Tanabe Pharma Corporation, MSD K.K., Mylan, Novartis Pharma K.K., Novo Nordisk Pharma Ltd, Ono Pharmaceutical Co., Ltd., Sanofi, Sanwa Kagaku Kenkyusho, Sumitomo Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Terumo Medical Corporation. Funding Japan Society for the Promotion of Science (JP19K20151)

The Efficacy of Acupuncture on Anthropometric Measures and the Biochemical Markers for Metabolic Syndrome: A Randomized Controlled Pilot Study.

Background Many previous studies have shown the potential therapeutic effect of acupuncture for metabolic syndrome (MetS). However, most of these studies were limited by short durations of observation and a lack of sham acupuncture as control. We designed a randomized controlled trial, used sham acupuncture as the control, and evaluated the efficacy over 12 weeks of treatment and 12 weeks of follow-up. Methods/Design The study was designed as a multicentre, parallel-group, randomized, double-blinded trial. 40 patients were randomly assigned to two groups: treatment group (treated with acupuncture) and control group (treated with sham acupuncture). Outcomes were measured at 4, 8, and 12 weeks and 3 months after treatment. Results 33 participants (17 in acupuncture group and 16 in control group) completed the treatment and the follow-up. Decreases from baseline in mean waist circumference (WC) and weight at the end of treatment were 4.85 cm (95% CI [2.405,5.595]) and 4.00 kg (95% CI [1.6208,4.4498]) in acupuncture group and 1.62 cm and 1.64 kg in control group (P < 0.01). The changes in mean glycosylated haemoglobin (HbA1c), triglycerides (TG), total cholesterol (TC), and blood pressure in acupuncture group were greater than the changes in control group (P < 0.05, P < 0.01). Conclusion Acupuncture decreases WC, HC, HbA1c, TG, and TC values and blood pressure in MetS.

Effect of DHA supplementation in a very low-calorie ketogenic diet in the treatment of obesity: a randomized clinical trial.

A VLCK diet supplemented with DHA, commercially available, was tested against an isocaloric VLCK diet without DHA. The main purpose of this study was to compare the effect of DHA supplementation in classic cardiovascular risk factors, adipokine levels, and inflammation-resolving eicosanoids. A total of obese patients were randomized into two groups: a group supplemented with DHA (n=14) (PnK-DHA group) versus a group with an isocaloric diet free of supplementation (n=15) (control group). The follow-up period was 6months. The average weight loss after 6months of treatment was 20.36±5.02kg in control group and 19.74±5.10kg in PnK-DHA group, without statistical differences between both groups. The VLCK diets induced a significant change in some of the biological parameters, such as insulin, HOMA-IR, triglycerides, LDL cholesterol, C-reactive protein, resistin, TNF alpha, and leptin.Following DHA supplementation, the DHA-derived oxylipins were significantly increased in the intervention group. The ratio of proresolution/proinflammatory lipid markers was increased in plasma of the intervention group over the entire study. Similarly, the mean ratios of AA/EPA and AA/DHA in erythrocyte membranes were dramatically reduced in the PnK-DHA group and the anti-inflammatory fatty acid index (AIFAI) was consistently increased after the DHA treatment (p<0.05). The present study demonstrated that a very low-calorie ketogenic diet supplemented with DHA was significantly superior in the anti-inflammatory effect, without statistical differences in weight loss and metabolic improvement.

Effect of maternal anemia on Placental ratio

Objective: To determine the effect of matemal anemia on placental ratio. Design: Cohort Study. Place and duration of study: Unit-1, Department of Gynaecology and Obstetrics 1, Sir Ganga Ram Hospital, Lahore from August 2002 to August 2003. Patients and the methods: One hundred pregnant women, 50 anemic and 50 having normal range of Hb were included in the study. After delivery, weight of the new bom and weight of placenta was recorded. The fetoplacental ratio was calculated for both groups and compared. Results: The mean weight of the newbom (±SD) in anemic group was 3.12 ± 0.45Kg and 3.18+0.35Kg in control group. The difference was statistically non-significant (P=0.445). The mean placental weight of anemic group was 0.58±0.13Kg and that of control group was 0.52±0.088Kg showing a significant increase (P<0.009). Feto-placental ratio was 0.193+0.035 (Mean±SD) in anemic patients and 0.166+0.024 in control group. FP ratio of anemic patients was significantly higher than control group (P<0.001). Conclusion: This study confirms that anemia during pregnancy is associated with significantly large placental weight and a high fetoplacental ratio.

The effect of prenatal lifestyle intervention on weight retention 12months postpartum: results of the Norwegian Fit for Delivery randomised controlled trial.

To examine the effect of a prenatal lifestyle intervention on postpartum weight retention (PPWR). Randomised controlled trial. Healthcare clinics in southern Norway. Healthy, nulliparous women with body mass index ≥19kg/m2 , age ≥18years, and singleton pregnancy of ≤20 gestational weeks. Women were randomised to intervention (dietary counselling twice by phone and access to twice-weekly exercise groups during pregnancy) or control group (standard prenatal care). Intervention compliance was defined post-factum as attending dietary counselling and ≥14 exercise classes. PPWR (weight measured postpartum minus self-reported pre-pregnancy weight) and the proportion of women returning to pre-pregnancy weight. Of 606 women randomised, 591 were included in an intention-to-treat analysis of pregnancy outcomes and 391 (64.5%) were analysed 12months postpartum. Mean PPWR was not significantly different between groups (0.66kg for intervention versus 1.42kg for control group, mean difference -0.77kg, 95% CI -1.81, 0.28; P=0.149). An increased proportion of intervention participants achieved pre-pregnancy weight (53% versus 43%, OR 1.50, 95% CI 1.003, 1.471; P=0.045). However, the difference was not statistically significant when we adjusted for missing data (adjusted odds ratio (OR) 2.23, P=0.067) using logistic mixed-effects models analysis. Women compliant with intervention had significantly lower PPWR than control participants, also after adjusting for potential confounders (adjusted mean diff -1.54kg, 95% CI -3.02, -0.05; P=0.039). The Norwegian Fit for Delivery intervention had little effect on PPWR, although women who were compliant with the intervention demonstrated significantly lower PPWR at 12months. Norwegian Fit for Delivery RCT: little effect of lifestyle intervention on weight retention 1year postpartum.

Heat stress amelioration measures in lactating Nili-Ravi buffaloes: Effect on body weight changes, dry matter intake, milk production and economics

The aim of the present study was to find out the effect of heat stress amelioration on body weight changes, dry matter intake, milk yield and economics in lactating Nili-Ravi buffaloes during hot-dry (HD; April to Mid June) and hot-humid (HH; Mid June to August) seasons under tropical climate. Forty two Nili-Ravi lactating buffaloes were uniformly divided into two groups of twenty one in each considering their lactation number, stage of lactation, body weight, dam’s milk yield and milk yield in current lactation. The control (T0) group buffaloes were kept in separate shed without any nutrient supplementation and modification in microclimate and management. The treatment (T1) group was supplemented with niacin, yeast, edible oil in feed and provided curtains and mist fans in the shed, and altered feeding time, frequency and type of ration. The overall mean body weights in control and treatment group buffaloes were noted to be 517.4 kg and 523.4 kg, respectively. Under HD and HH seasons, mean body weights at different fortnights in treatment group buffaloes were 515.6 kg and 531.1 kg, respectively. In control group, the respective values were 512 kg and 522.7 kg. Although the body weights were higher in treatment than control group, there were no statistically significant differences between two experimental groups. The overall mean daily total dry matter intake (TDMI), dry matter intake through concentrate (CDMI), dry matter intake through dry fodder (DFDMI) and dry matter intake through green fodder (GFDMI) were noted to be 13.04, 4.21, 1.02, 7.92, 14.13, 4.24, 1.17 and 8.65 kg in control and treatment group buffaloes, respectively. Under both seasons, treatment group buffaloes consumed more dry matter than control group throughout the experimental period. The values were also differed significantly (ranged from P&lt;0.05 to P&lt;0.0001) between two groups. The overall mean values of fortnightly total milk production were 103.2 kg in control group and 121.5 kg in treatment group. Throughout the period, treatment group buffaloes produced more milk than control. Milk production was also significantly (P&lt;0.0001) differed between control and treatment groups under two seasons. The daily average additional input cost per buffalo was maximum 22/- and additional income per buffalo was minimum 35/-. Therefore, the net profit was around 13/- per buffalo per day. The input: output ratio was calculated to be 1:1.59. It can be concluded that the use of such types of housing, nutritional and management interventions in the form of one package not only helps to maintain body weight but also increases dry matter intake and favours economic milk production in lactating buffaloes through reducing heat stress during hot-dry and hot-humid seasons in tropical climate.

Weight loss with a modified Mediterranean-type diet using fat modification: a randomized controlled trial.

There is evidence that Mediterranean diets with a high proportion of olive oil and nuts can be effective for weight management and prevention of cardiovascular disease. It might be difficult for populations with other eating habits to follow such diets. Therefore, a modified Mediterranean-type diet using fat modification through neutral and butter-flavored canola oil, walnuts and walnut oil with two portion-controlled sweet daily snacks was tested in Germany. Randomized waiting-list control study with overweight/grade 1 obese subjects: 12-week self-help modified Mediterranean-type diet, 6 weeks of diet plans and 6 weeks of weight loss maintenance training. Trial duration was 12 months. Intervention group (IG) included 100 participants (average age of 52.4 years, weight 85.1 kg and body mass index (BMI) 30.1 kg/m(2)), waiting-list control group (CG) included 112 participants (52.6 years, 84.1 kg and 30.1 kg/m(2)). Per-protocol weight loss after 12 weeks was 5.2 kg in IG vs 0.4 kg in CG (P ⩽ 0.0001), BMI -1.8 vs -0.1 kg/m(2) (P ⩽ 0.0001), waist circumference -4.7 vs -0.9 cm (P ⩽ 0.0001). Triglycerides, total cholesterol and LDL cholesterol improved significantly in IG but not in CG. One-year dropouts: 44% in IG and 53% in CG. Weight loss after 12 months: 4.2 kg (pooled data). A five-meal modified Mediterranean-type diet with two daily portion-controlled sweet snacks was effective for weight management in a self-help setting for overweight and grade 1 obese subjects. Fat modification through canola oil, walnuts and walnut oil improved blood lipids even at 12 months.

New technologies aiding dietary programmes for weight control: the oral glucose spray

To determine whether the administration of small amounts of glucose through an oral spray device (GSD) facilitates weight loss in overweight/obese subjects involved in a lifestyle modification programme. We randomly assigned 56 overweight/obese subjects to either the treatment group (n = 32) or the control group (n = 24). All subjects in both groups followed a structured dietary programme of 6,280.2 kJ (1,500 kcal)/day and exercised minimum 150 min a week and were followed-up for a period of 60 days. Subjects assigned to the treatment group were asked to spray, during early symptoms of neuroglycopenia, 10 puffs by GSD. GSD is a device that delivers to the buccal mucosa 50 mg of glucose per puff. A mean weight loss of 3.5 ± 3.0 kg in GSD-treated group compared to 1.7 ± 2.1 kg in control group (p = 0.01) was observed. Significant differences regarding reduction of BMI (-1.3 ± 1.0 vs. -0.7 ± 0.8 kg/m2; p = 0.01) and waist circumference (-3.5 ± 3.2 vs. -0.9 ± 3.5 cm; p = 0.02) were also detected. A short-term use of GSD, in association with dietary restriction and exercise, is helpful in improving weight loss and in reducing waist circumference in overweight/obese subjects.

Comparative study on the clinical-nutritional status of obese postmenopausal women on a weight loss programme based on prepared dishes

Few studies have evaluated the efficacy and reliability of weight loss-focussed prepared food dishes in obese post-menopausal women. To compare the efficacy of a weight loss programme based on a balanced hypocaloric diet using prepared dishes* with that of a similar programme based on standard commercially available foods and with a non-intervened control group. A further aim was to evaluate the subjectivity of participants in the preparation of the diet-adjusted dishes based on usually consumed products. Obese post-menopausal women aged between 55 and 65 years. Controlled longitudinal interventional study. The sample of 75 female volunteers were divided into three groups of 25 women: a control group, who continued to consume their usual non-dietary adjusted meals (CG), an intervened group, treated with a diet adjusted to their individual requirements and based on standard commercially available food (SG), and another intervened group, treated with a similarly adjusted diet but based on prepared dishes (PG). Data were gathered on anthropometric variables, consumption habits and physical activity levels, and clinical-nutritional controls were conducted at the start and every two weeks to the end of the 8-week study in order to evaluate biochemical changes. The weight loss was slightly higher in the prepared-dishes group (PG) than in the standard food diet group (SG), but the difference was not statistically significant, whereas it was considerably higher in both groups than in the non-dietary adjusted control group (CG) and this difference was highly significant (losses of 7.60 kg in PG and 7.01 kg in SG versus 2.10 kg in CG (p < 0.01). However, the PG showed a significantly higher (p < 0.01) loss of fatty mass and abdominal circumference versus the SG women. More weight was lost by the two groups treated with a diet based on prepared dishes or usual food items in comparison to untreated controls, but the diet based on prepared dishes obtained more reliable and higher quality outcomes, achieving a positive change at fatty compartment level and in the abdominal circumference.

KMC facilitates mother baby attachment in low birth weight infants

To determine whether Kangaroo mother care (KMC) facilitates mother baby attachment in low birth weight infants. Over 16 month period 110 neonates were randomized into kangaroo mother care group and control group using a random number table. The kangaroo group was subjected to Kangaroo mother care for at least 6 hours per day. The babies also received kangaroo care after shifting out from NICU and at home. The control group received standard care (incubator or open care system). After 3 months followup, structured maternal interview was conducted to assess attachment between mothers and their babies. Mean birth weight was 1.69 +/- 0.11 Kg in KMC group compared to 1.690 +/- 0.12 Kg in control group (p>0.05). Mean gestational age was 35.48 +/- 1.20 week in KMC group and 35.04+/-1.09 week in the control group (p>0.05). KMC was initiated at a mean age of 1.72+/-0.45 days. The duration of KMC in first month was 10.21+/-1.50 hour, in the 2nd month was 10.03+/-1.57 hour and in the 3rd month was 8.97+/-1.37 hours. The duration of hospital stay was significantly shorter in the KMC group (3.56+/-0.57 days) compared to control group (6.80+/-1.30 days). The total attachment score (24.46+/-1.64) in the KMC group was significantly higher than that obtained in control group (18.22+/-1.79, p< 0.001). In KMC group, mother was more often the main caretaker of the baby. Mothers were significantly more involved in care taking activities like bathing, diapering, sleeping with their babies and spent more time beyond usual care taking. They went out without their babies less often and only for unavoidable reasons. They derived greater pleasure from their babies. KMC facilitates mother baby attachment in low birth weight infants.

Autologous Hemopoietic Stem-Cell Transplantation in Patients with Preexisting Cardiac Abnormalities.

INTRODUCTION: High dose chemotherapy and autologous hemopoietic stem cells transplantation (AHSCT) represents an useful treatment for patients undergoing hematological diseases. Relapsed lymphomas, acute leukemias and multiple myeloma achieve a better outcome with a low incidence of complications and mortality related to the procedure. Assessment of pre-transplant organ function (including cardiopulmonary, kidney and liver) is a routine part of eligibility criteria for AHSCT protocols. Left ventricle (LV) function has been considered one of the most important risk factor in predicting complications or mortality related to transplantation, although, previous studies have not confirmed these issues. The purpose of our retrospective study was to investigate differences among clinical outcome, therapeutic requirements and Transplant Related Mortality (TRM) in patients (pts) undergoing AHSCT with and without cardiac pathology.METHODS: We retrospectively reviewed data from 290 pts undergoing AHSCT between September 1991 to June 2006. Routine pretransplant evaluation included ECG and Bidimensional Echocardiography (BE). We compared Group A including pts with any of the following: Impairment of Left Ventricle systolic function (ILVF) (Ejection fraction <50%), Ischaemic cardiac disease (ICD), Dilated myocardiopathy (DM), Valvulopathy (VP), Chronic arrythmia (CA), Wall motion abnormalities (WMA), and Restrictive myocardiopathy (RM); and Group B pts with no cardiac abnormalities. Clinical course, infectious, cardiopulmonary or other complications, hematological recovery time and TRM were reviewed for each enrolled pts. Statistical analysis was performed using chi square tests.RESULTS: Group B (control) included 269 of 290 evaluated pts without cardiac abnormalities and group A included 21 pts with the following criteria: 5 pts: DM, 5 pts: ICD, 6 pts: VP, 2 pts: CA, 2 pts: RM and 1 pts: ILVF. Mean age in Group A was higher than control group (49,1 ±13 vs 36,1 ±16) p<0,001. No differences was found between both groups about: Gender (male 58% vs female 51%), Diagnosis (Group A: Non-Hodgkin's Lymphoma 38,1%, Hodgkin's Disease 14,3%, Acute Leukemia 9,5%, Multiple Myeloma 38,1% vs Group B: Non-Hodgkin's Lymphoma 24,5%, Hodgkin's Disease 26,7%, Acute Leukemia 17,4%, Multiple Myeloma 19,3%), Stem cell source (Group A: Peripheral Blood Stem cells 90,5% vs 72% in group B) or Mean number of administered CD 34 positive cells (4,2 × 106 ±2,5/kg in group A vs 7,066 ±3,4/kg in control group). Comparative Results between Groups are shown in the table:CONCLUSIONS: No significant differences were observed among hospitalization time, infectious episodes, extracardiac toxicities and transplant related mortality. The incidence of cardiac complications was higher but this did not increase the number of TRM. These results prevent us about rigid eligibility criteria that potentially denie patients the benefit of AHSCT.Group AGroup BHospitalization days*23±524±10,3Neutrophil Engrafment (days)*11,3±3,712,05±4,3Days on antibiotics*11±4,111,6±5,5Positive Blood Cultures(%)*23,827,1Platelet engrafment (days)*13,5915,66Packed red cell transfused (n)*4,23,22Platelet transfused (n)*5,95,64Acute Renal dysfunction(%)*9,54Congestive Heart Failure(%)**14,32,8Hepatotoxicity(%)*14,38,3Pulmonary Injury(%)*4,73,8Arrythmias(%)**14,32,9Grade III–IV Mucositis(%)*42,951TRM(%)*4,83,42* p NS **p<0,05

The use of amaranth (genus AmaranthusL.) in the diets for broiler chickens

The objective of our study was to test amaranth grain or dried biomass in the diet for broiler chickens as a resource of protein replacing animal protein. Further, the effect of amaranth on broiler performance, carcass characteristics and meat quality were assessed in a feeding trial. The experimental groups of broilers were fed feed mixtures with crude amaranth grain (AC), heat processed amaranth grain (AP) or dried above-ground biomass (AB). Control groups (C) received the diet containing animal proteins. The results obtained in the experimental groups of broiler chickens can be compared to the control group in all the production indicators under investigation. On day 42 of the experiment, live weight (g) of female broilers ranged from 2 205.1 &amp;plusmn; 152.5 (AP) to 2 254.0 &amp;plusmn; 136.5 (C), and that of male broilers from 2 375.1 &amp;plusmn; 233.0 (AC) to 2 506.0 &amp;plusmn; 286.0 (C). Feed conversion ranged from 1.80 kg in control group of male broiler chickens to 1.91 kg in experimental group of male broilers (AB). Percentage yield in female broiler chickens ranged from 70.8 &amp;plusmn; 1.74 (AB) to 72.4 &amp;plusmn;3.34(AC) or 72.4 &amp;plusmn; 1.98 (C), and in male broilers from 72.8 &amp;plusmn;3.55(AP) to 75.1 &amp;plusmn;2.44(AB). Our results showed that amaranth can fully replace meat-and-bone meals in the diets for broiler chickens.

MATERNAL RISK FACTORS AFFECTING BIRTH WEIGHT OF NEWBORN

st September to 31 st December 2001. METHODS: One hundred live born LBW babies were selected against 65 normal birth weight babies as control for this study. Information regarding maternal biosocial, medical and obstetric problems during pregnancy was recorded on a specified proforma and data analysis was done through SPSS 10.0 version and results were interpreted in terms of P-values. RESULTS: The mean birth weight of LBW babies was 1.96 kg as compared to 3.2 kg in control group. Sixty-nine percent of cases were preterm with male predominance. Main factors identified were poverty, maternal malnutrition, short birth interval, teenage mother, lack of antenatal care, anemia, toxemia, antepartum hemorrhage, renal disease and malaria. CONCLUSION: Maternal biosocial, medical and obstetric factors have strong association with LBW. To overcome this problem, health education of mothers and strengthening of the health care facilities for mother and children in the community are required.

생봉독 처리가 돼지의 생산성에 미치는 효과

This experiment was carried out to investigate effects of honeybee venom treatment on the body weight gain, feed conversion and growth rate' in pigs. One hundred twenty nine piglets(LY) from 12 sows were allocated into two groups; honeybee venom-treated group (66 piglets from 6 sows) and non-treated control group (63 piglets from 6 sows). Natural honeybee venom was administrated at 0, 3, 14, 30, and 74 days after birth. The acupoints were Hai-men(ST-25), Du-kou(CV-8) and liao-chao(GV-I) points at 0 day, the regions of castration and tail ampution at 3 days, liao-chao(GV-1) and Bai-hui(GV-20) points at 14(weaning), 30(move into piglet stall) and 74(move into grower stall) days after birth. Control group was injected 1 ml of saline to the same site. Average body weight at 150 days after birth was 98.44 kg in bee venom treated group and 86.24 kg in control group, respectively. Average body weight of treated group was significantly increased by 14.15%(P < 0.0001). Average daily gain of bee venom treated group and control group were 649 g and 569 g, respectively, increased by 14.06%(P< 0.0001). Feed conversion of the treated group was 2.21 and control group was 2.49, increased by 11.25% in control group(P < 0.001). Survival rate at weaning was 95.5 % in treated group and 92.0% in control group, at growing(74 days after birth) was 92.4% in treated group and 85.7% in control group and survival rate at finishing(l50 days after birth) was 89.5 % and 79.4 %, respectively. Collecting together, the results in this study showed that growth performance and feed conversion were increased by treatment of natural honeybee venom to pigs. These results suggested that the treatment of bee venom could be used effectively for the increase productivity of livestock industry.

P0912 DOES THE STRAIN BIFIDOBACTERIUM LONGUM GS INDUCED MICROFLORA IMBALANCE IN PIGLETS DURING GROWING PERIOD?

Introduction: The time of weaning can present a considerable challege to the health of the young human and pig. Weaning frequently results in growth suppression and diarrhea. Entero-bacteria is often associated with post weaning secretory diarrhea. Bifibobacteria are among the predominant and benefic colonic microflora, that were recently introduced into several fermented dairy products. The aim of the present study was to evaluate the effect of the strain B. longum GS in the intestinal microbial balance in weaning pigs. Methods: 20 piglets weaned weighed 32.7 ± 3.6 kg were selected for this study. 60 days older, animals were divided into two groups: control group (n=10), they received a standard diet, the treated group (n=10), fed either the strandard diet, fermented milk by the strain Bifidobacterium longum GS (60ml/kg/day) (109–1010 UFC/ml/day) during 12 weeks. Animals were weighed daily during the treatment and feces were harvested for bacteriological analysis before treatment (day 0), during the treatment (day 14, 36, 45, 80). The number of colony forming units for samples was expressed per gram of fecal content. All results showed a normal distribution and were expressed as mean ± standard error. Unpaired Student’s t-test was used for comparison means of positive cultures. Results: Animals weight did not change during the treatment: 69,1± 9,1 kg for control group and 67,7 ± 11.04 kg for treated group. The strain B.longum GS alters the gut microecology. The numbers of enterobacteria significantly decrease (p<0.05), However, Bacteroides fragilis group were relatively lower during the experimentation in the two groups (p<0.05). No modification was observed in Clostridium sp population. Bifidobacteria and lacto-bacilli were predominat but no perturbation was shown during the treatment. Conclusion: The efficacity of the strain B. longum GS was likely during the first months of life with adequate posology. Reference(S): none

Effect of Chromium Nanoparticle on Growth Performance, Carcass Characteristics, Pork Quality and Tissue Chromium in Finishing Pigs

The study was conducted to evaluate the effect of chromium nanoparticle (CrNano) on growth, carcass characteristics, pork quality, and tissue chromium in finishing pigs. A total of 100 Duroc×Landrace×Yorkshire barrows (average initial BW of 64.78±0.83 kg) were divided into 10 pens, 10 pigs per pen. 5 pens of pigs were fed with control diet (corn-soybean meal, 1.05% Lys) and others were fed with control diet addition with 200 µg/kg Chrome (Cr) from CrNano. During the trial, all pigs were given free access to feed and water. After 35 days trial, 10 pigs from each each treatment (weight similar to average group weight, 91.34±1.31 kg for control group, and 92.26±0.56 kg for CrNano treated group) were sacrificed to measure carcass characteristics, pork quality, and to collect the samples of longissimus muscle, liver, kidney and heart. The results indicated that the addition of 200 µg/kg CrNano decreased feed: gain ratio by 3.56% (p<0.05) compared to the control group. Pigs fed CrNano had 14.06% higher (p<0.05) carcass lean percentage, 19.96% (p<0.05) larger longissimus muscle area and 25.53% lower (p<0.05) carcass fat percentage, 18.22% lower (p<0.05) backfat thickness. Drip loss in chops from pigs fed CrNano was decreased by 21.48% (p<0.05) and weights of longissimus muscle and semimembranosus were increased by 16.33% (p<0.05) and 14.87% (p<0.05) respectively. In addition, supplemental CrNano resulted in 184.11% (p<0.05), 144.99% (p<0.05), 88.13% (p<0.05) and 52.60% (p<0.05) increment of Cr concentration in longissimus muscle, liver, kidney and heart, respectively. These results suggest that supplemental CrNano has beneficial effects on carcass characteristics, pork quality and individual skeletal muscle weight, increase tissue chromium concentration in selected muscle and organs. (Asian-Aust. J. Anim. Sci. 2004. Vol 17, No. 8 : 1118-1122)